Skip to main content

Pediatric B-ALL: A Cytogenomic Update

From the 2022 Joint Annual Meeting (recorded 6/28/2022)
Presented by Carlos A. Tirado, PhD, FACMGG

This presentation describes the genes and chromosomal abnormalities seen in pediatric B-cell acute lymphoblastic lymphoma (B-ALL). Case studies with different chromosomal abnormalities, which are crucial in the diagnosis and prognosis of pediatric B-ALL, will also be reviewed.

At the conclusion of this presentation, participants will be able to:

  • Recognize the main chromosomal abnormalities seen in Pediatric B-ALL.
  • Discuss the genes, gene fusions and rearrangements or amplifications of the genes involved in pediatric B-ALL.
  • Describe the main mechanisms of genes, chromosomal abnormalities and mutations seen in pediatric B-ALL.

ASCLS is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. One (1) P.A.C.E. ® contact hour and one (1) Florida credit hour in the area of Molecular (Cytogenetics) will be awarded to participants. ASCLS P.A.C.E.® is accepted by the ASCP/ASCLS/AGT Board of Certification and all states, including Florida and California, as an approved provider of continuing education for recertification and licensure. ASCLS is an approved provider with CE Broker for Florida licensees.

This Advanced-level program is appropriate for laboratory professionals working in clinical, public health and academic settings